Skip Navigation

A Phase II Randomized Trial of Olaparib NSC-747856 Administered Concurrently with Radiotherapy versus Radiotherapy Alone for Inflammatory Breast Cancer

Brief Summary

Type:
Breast Cancer

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03598257

Study #:
STUDY00143275

Start Date:
Mar 10, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03598257

View Complete Trial Details & Eligibility at ClinicalTrials.gov